Frontiers of Medicine
>> 2019,
Volume 13,
Issue 5
doi:
10.1007/s11684-018-0637-9
REVIEW
ECRG4: a new potential target in precision medicine
. Medical College, Hubei University of Arts and Science, Xiangyang 441053, China.. State Key Laboratory of Cancer Biology, Department of Medical Genetics and Developmental Biology, Fourth Military Medical University, Xi’an 710032, China
Accepted: 2018-07-12
Available online: 2018-07-12
Next
Previous
Abstract
Given the rapid development in precision medicine, tremendous efforts have been devoted to discovering new biomarkers for disease diagnosis and treatment. Esophageal cancer-related gene-4 ( ), which is initially known as a new candidate tumor suppressor gene, is emerging as a sentinel molecule for gauging tissue homeostasis. ECRG4 is unique in its cytokine-like functional pattern and epigenetically-regulated gene expression pattern. The gene can be released from the cell membrane upon activation and detected in liquid biopsy, thus offering considerable potential in precision medicine. This review provides an updated summary on the biology of ECRG4, with emphasis on its important roles in cancer diagnosis and therapy. The future perspectives of ECRG4 as a potential molecular marker in precision medicine are also discussed in detail.
京公网安备 11010502051620号
